Table 1.
Characteristic | Median (interquartile range) |
---|---|
Age at baseline | 31 (25–35) |
BMI (kg/m2) | 39 (35–47) |
Weight (kg) | 107 (93–120) |
Pre-LP headache severity (NRS) | 4 (1–6) (mean 3.6 (SD: 2.8)) |
LP opening (cmCSF) | 32 (28–37) |
LP closing (cmCSF) | 19 (17–21) |
Amount CSF drained (ml) | 10 (10–12) |
RBC in CSF (cmm)# | 7 (1–36) |
Depth from skin to CSF (mm) as measured by ultrasound## | 67 (61–74) |
Frisén Grade | Right eye 2 (1–2) Left eye 2 (1–3) |
Percentage (visits) |
|
Ethnicity | |
White | 91% (60) |
Mixed/multiple ethnic group | 5% (3) |
Asian/Asian British | 3% (2) |
Black/African/Caribbean | 2% (1) |
Analgesic on day### | 24% (11) |
Headache preventative therapy | 24% (16) |
Acetazolamide | 27% (18) |
Headache phenotypes* | |
Migraine-like and probable migraine-like | 80% (53) |
Attributed to IIH | 35% (23) |
Tension type-like | 14% (9) |
Other | 8% (5) |
Not classifiable | 11% (7) |
Note: Where data is missing, the number of visits included is indicated as # = 61, ## = 22, ### = 46.
Patients may have experienced more than one headache phenotype at baseline. Headaches exist in the setting of active IIH thus are not a primary headache; the phenotype of the headaches are classified according to the ICHD-3 beta.